Brief: Fusion Pharmaceuticals And Niowave Announce Actinium-225 Collaboration And Supply Agreement

Fusion Pharmaceuticals

10/06/2022 12:48

June 10 (Reuters) - Fusion Pharmaceuticals Inc  FUSN.O :
    * FUSION PHARMACEUTICALS AND NIOWAVE ANNOUNCE ACTINIUM-225
COLLABORATION AND SUPPLY AGREEMENT
    * FUSION PHARMACEUTICALS INC - FUSION TO INVEST $5M FOR
GUARANTEED
ACCESS TO ACTINIUM-225 SUPPLY
    * FUSION PHARMACEUTICALS - AS PART OF AGREEMENT, WILL ALSO
HAVE AN
OPTION TO INVEST IN FUTURE PRODUCTION OF ACTINIUM-225 TO SCALE
WITH FUSION'S NEEDS
    * FUSION PHARMACEUTICALS INC - FUSION WILL HAVE GUARANTEED
ACCESS
TO A PRE-DETERMINED PERCENTAGE OF NIOWAVE'S CAPACITY OF
RESULTING ACTINIUM-225
    * FUSION PHARMACEUTICALS INC -  FUSION WILL ALSO HAVE
PREFERRED
ACCESS TO ANY EXCESS SUPPLY OF ACTINIUM-225 PRODUCED

Source text for Eikon:  ID:nCNWK2YYka 
Further company coverage:  FUSN.O 

 ((reuters.briefs@thomsonreuters.com;))